Structure |
Chemical Name |
CAS |
MF |
|
NVP-BEZ 235 |
915019-65-7 |
C30H23N5O |
|
BKM120 (NVP-BKM120, Buparlisib) |
944396-07-0 |
C18H21F3N6O2 |
|
Pictilisib |
957054-30-7 |
C23H27N7O3S2 |
|
LY 294002 HYDROCHLORIDE |
154447-36-6 |
C19H17NO3 |
|
CAL-101 |
870281-82-6 |
C22H18FN7O |
|
Temsirolimus |
162635-04-3 |
C56H87NO16 |
|
Perifosine (KRX-0401) |
157716-52-4 |
C25H52NO4P |
|
MK-2206 2HCl |
1032350-13-2 |
C25H22ClN5O |
|
API-2 |
35943-35-2 |
C13H16N6O4 |
|
SB216763 |
280744-09-4 |
C19H12Cl2N2O2 |
|
KU-0063794 |
938440-64-3 |
C25H31N5O4 |
|
AZD-8055 |
1009298-09-2 |
C25H31N5O4 |
|
PP242 |
1092351-67-1 |
C16H16N6O |
|
XL147 |
956958-53-5 |
C21H16N6O2S2 |
|
5-(6-Quinoxalinylmethylene)-2,4-thiazolidinedione |
648450-29-7 |
C12H7N3O2S |
|
PI-103 |
371935-74-9 |
C19H16N4O3 |
|
ZSTK474 |
475110-96-4 |
C19H21F2N7O2 |
|
GSK-2126458 |
1086062-66-9 |
C25H17F2N5O3S |
|
3-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[5,6-e]pyrimidin-7-yl]-N-methylbenzamide |
1009298-59-2 |
C25H30N6O3 |
|
N-(2,3-Dihydro-7,8-dimethoxyimidazo[1,2-c]quinazolin-5-yl)-3-pyridinecarboxamide |
677338-12-4 |
C18H17N5O3 |
|
2-[(6-Amino-9H-purin-9-yl)methyl]-5-methyl-3-(2-methylphenyl)-4(3H)-quinazolinone |
371242-69-2 |
C22H19N7O |
|
LY2090314 |
603288-22-8 |
C28H25FN6O3 |
|
AZD5363 |
1143532-39-1 |
C21H25ClN6O2 |
|
ZOTAROLIMUS |
221877-54-9 |
C52H79N5O12 |
|
PIK-93 |
593960-11-3 |
C14H16ClN3O4S2 |
|
6-Amino-N-[3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenyl]-3-pyridinecarboxamide |
371942-69-7 |
C25H21N7O3 |
|
OSU-03012 |
742112-33-0 |
C26H19F3N4O |
|
PF-4708671 |
1255517-76-0 |
C19H21F3N6 |
|
AT7867 |
857531-00-1 |
C20H20ClN3 |
|
N-Ethyl-N'-[4-[5,6,7,8-tetrahydro-4-[(3S)-3-methyl-4-morpholinyl]-7-(3-oxetanyl)pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea |
1207360-89-1 |
C24H32N6O3 |
|
GSK-3BETA INHIBITOR XII |
601514-19-6 |
C18H14N4O2 |
|
2,6-PYRIDINEDIAMINE, N6-[2-[[4-(2,4-DICHLOROPHENYL)-5-(1H-IMIDAZOL-1-YL)-2-PYRIMIDINYL]AMINO]ETHYL]-3-NITRO- |
252935-94-7 |
C20H17Cl2N9O2 |
|
PF-05212384 |
1197160-78-3 |
C32H41N9O4 |
|
(S)-1-[4-[[2-(2-Aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one |
1032754-93-0 |
C23H30N8O3S |
|
IPI 145 |
1201438-56-3 |
C22H17ClN6O |
|
N-[3-[[5-Iodo-4-[[3-[(2-thienylcarbonyl)amino]propyl]amino]-2-pyrimidinyl]amino]phenyl]-1-pyrrolidinecarboxamide |
702675-74-9 |
C23H26IN7O2S |
|
OSI-027 |
936890-98-1 |
C21H22N6O3 |
|
9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h]-1,6-naphthyridin-2(1H)-one |
1223001-51-1 |
C24H15F3N4O |
|
PaloMid 529 (P529) |
914913-88-5 |
C24H22O6 |
|
A-674563 |
552325-73-2 |
C22H22N4O |
|
GSK2636771 |
1372540-25-4 |
C22H22F3N3O3 |
|
GDC-0068 |
1001264-89-6 |
C24H32ClN5O2 |
|
BIO |
667463-62-9 |
C16H10BrN3O2 |
|
PHT-427 |
1191951-57-1 |
C20H31N3O2S2 |
|
1-AZAKENPAULLONE |
676596-65-9 |
C15H10BrN3O |
|
42-(Dimethylphosphinate)rapamycin |
572924-54-0 |
C53H84NO14P |
|
AZD 1080 |
612487-72-6 |
C19H18N4O2 |
|
SB 415286 |
264218-23-7 |
C16H10ClN3O5 |
|
4-BENZYL-2-METHYL-1,2,4-THIADIAZOLIDINE-3,5-DIONE |
327036-89-5 |
C10H10N2O2S |
|
5-[[5-(4-Fluoro-2-hydroxyphenyl)-2-furanyl]methylene]-2,4-thiazolidinedione |
900515-16-4 |
C14H8FNO4S |
|
CCT128930 |
885499-61-6 |
C18H20ClN5 |
|
BX-912 |
702674-56-4 |
C20H23BrN8O |
|
5-(4-aMino-1-isopropyl-1H-pyrazolo[3,4-d]pyriMidin-3-yl)benzo[d]oxazol-2-aMine |
1224844-38-5 |
C15H15N7O |
|
AR-A014418 |
487021-52-3 |
C12H12N4O4S |
|
CH5132799 |
1007207-67-1 |
C15H19N7O3S |
|
AKT Kinase Inhibitor |
842148-40-7 |
C16H19N7O3 |
|
PI-3065 |
955977-50-1 |
C27H31FN6OS |
|
BI-D1870 |
501437-28-1 |
C19H23F2N5O2 |
|
PIK-294 |
900185-02-6 |
C28H23N7O2 |
|
WYE-687 |
1062161-90-3 |
C28H32N8O3 |
|
N-[4-[1-(1,4-Dioxaspiro[4.5]dec-8-yl)-4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]phenyl]-N'-methylurea |
1144068-46-1 |
C27H33N7O4 |
|
Bikinin |
188011-69-0 |
C9H9BrN2O3 |
|
PKI-402 |
1173204-81-3 |
C29H34N10O3 |
|
4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione |
865854-05-3 |
C19H14N2O2S |
|
AT-13148 |
1056901-62-2 |
C17H16ClN3O |
|
GSK-2110183C |
1047644-62-1 |
C18H17Cl2FN4OS |
|
IM-12 |
1129669-05-1 |
C22H20FN3O2 |
|
XL-388 |
1251156-08-7 |
C23H22FN3O4S |
|
AZD-2858 |
486424-20-8 |
C21H23N7O3S |
|
A66 |
1166227-08-2 |
C17H23N5O2S2 |
|
VS-5584 |
1246560-33-7 |
C17H22N8O |
|
Torin 1 |
1222998-36-8 |
C35H28F3N5O2 |
|
WAY-600 |
1062159-35-6 |
C28H30N8O |
|
NVP-BGT226 |
1245537-68-1 |
C28H25F3N6O2.C4H4O4 |
|
BAY 80-6946 (Copanlisib) |
1032568-63-0 |
C23H28N8O4 |
|
HS-173 |
1276110-06-5 |
C21H18N4O4S |
|
LY2584702 |
1082949-67-4 |
C21H19F4N7 |
|
LY-2584702 (tosylate salt) |
1082949-68-5 |
C28H27F4N7O3S |
|
AS 604850 |
648449-76-7 |
C11H5F2NO4S |
|
5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidenedione |
958852-01-2 |
C18H11N3O2S |
|
GSK 2334470 |
1227911-45-6 |
C25H34N8O |
|
2-[[(1R)-1-[7-methyl-2-(4-morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid |
1173900-33-8 |
C22H24N4O4 |
|
CAY10505 |
1218777-13-9 |
C14H8FNO3S |
|
BML-275 |
1219168-18-9 |
C24H27Cl2N5O |
|
CZC24832 |
1159824-67-5 |
C15H17FN6O2S |
|
XL765 |
1349796-36-6 |
C31H29N5O6S |
|
KP372-1 |
329710-24-9 |
C10H4N6O |
|
3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol |
677297-51-7 |
C18H14N6O2 |
|
PIK-293 |
900185-01-5 |
C22H19N7O |
|
TG 100713 |
925705-73-3 |
C12H10N6O |
|
7-benzyl-10-(2-Methylbenzyl)-2,6,7,8,9,10-hexahydroiMidazo[1,2-a]pyrido[4,3-d]pyriMidin-5(3H)-one |
41276-02-2 |
C24H26N4O |
|
WYE-354 |
1062169-56-5 |
C24H29N7O5 |
|
PIK-75 Hydrochloride |
372196-77-5 |
C16H15BrClN5O4S |
|
WZ4003 |
1214265-58-3 |
C25H29ClN6O3 |
|
5-(6-(3-Methoxyoxetan-3-yl)-4-Morpholinothieno[3,2-d]pyriMidin-2-yl)pyriMidin-2-aMine |
1394076-92-6 |
C19H22N6O3S |
|
MHY1485 |
326914-06-1 |
C17H21N7O4 |
|
H-89 DIHYDROCHLORIDE HYDRATE |
130964-39-5 |
C20H20BrN3O2S.2ClH.H2O |